Partners turned into prey as insurers, drug plans get squeezed
Published
8 Min Read
More From Employee Benefit News
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Healthcare costs are forcing employers to reconsider their benefits strategy
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
GLP-1s push health plan costs to 15-year high
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
How to stabilize your GLP-1 budget amid increasing demand, cost
As healthcare prices and employee interest soar for the blood glucose and weight control drugs, offering coverage through lifestyle spending or specialty care accounts can help contain costs.
Benefits Think PBM playbook, part 2: Changes to the market and the value of a pharmacy benefits expert
A look at traditional PBMs and pass-through models, potential savings areas, developments and partnering with the right consultant.
